[1]
Leung AKC, Leung AAM, Wong AHC, Hon KL. Travelers' Diarrhea: A Clinical Review. Recent patents on inflammation & allergy drug discovery. 2019:13(1):38-48. doi: 10.2174/1872213X13666190514105054. Epub
[PubMed PMID: 31084597]
[2]
Koulinska I, Riester K, Chalkias S, Edwards MR. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study. Clinical therapeutics. 2018 Dec:40(12):2021-2030.e1. doi: 10.1016/j.clinthera.2018.10.013. Epub 2018 Nov 15
[PubMed PMID: 30447891]
Level 1 (high-level) evidence
[3]
Hailey FJ, Newsom JH. Evaluation of bismuth subsalicylate in relieving symptoms of indigestion. Archives of internal medicine. 1984 Feb:144(2):269-72
[PubMed PMID: 6365007]
[4]
Heather CS. Travellers' diarrhoea. BMJ clinical evidence. 2015 Apr 30:2015():. pii: 0901. Epub 2015 Apr 30
[PubMed PMID: 25928418]
[5]
Patel AR, Oheb D, Zaslow TL. Gastrointestinal Prophylaxis in Sports Medicine. Sports health. 2018 Mar/Apr:10(2):152-155. doi: 10.1177/1941738117732733. Epub 2017 Sep 27
[PubMed PMID: 28952896]
[6]
de Boer WA, Tytgat GN. Regular review: treatment of Helicobacter pylori infection. BMJ (Clinical research ed.). 2000 Jan 1:320(7226):31-4
[PubMed PMID: 10617524]
[7]
Testerman TL, Morris J. Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment. World journal of gastroenterology. 2014 Sep 28:20(36):12781-808. doi: 10.3748/wjg.v20.i36.12781. Epub
[PubMed PMID: 25278678]
[8]
Miehlke S, Bayerdörffer E, Graham DY. Treatment of Helicobacter pylori infection. Seminars in gastrointestinal disease. 2001 Jul:12(3):167-79
[PubMed PMID: 11478749]
[9]
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. The American journal of gastroenterology. 2017 Feb:112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10
[PubMed PMID: 28071659]
[10]
Rendi-Wagner P, Kollaritsch H. Drug prophylaxis for travelers' diarrhea. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2002 Mar 1:34(5):628-33
[PubMed PMID: 11803509]
[11]
Steffen R. Worldwide efficacy of bismuth subsalicylate in the treatment of travelers' diarrhea. Reviews of infectious diseases. 1990 Jan-Feb:12 Suppl 1():S80-6
[PubMed PMID: 2406861]
[13]
Goldman RD. Bismuth salicylate for diarrhea in children. Canadian family physician Medecin de famille canadien. 2013 Aug:59(8):843-4
[PubMed PMID: 23946025]
[14]
Pitz AM, Park GW, Lee D, Boissy YL, Vinjé J. Antimicrobial activity of bismuth subsalicylate on Clostridium difficile, Escherichia coli O157:H7, norovirus, and other common enteric pathogens. Gut microbes. 2015:6(2):93-100. doi: 10.1080/19490976.2015.1008336. Epub
[PubMed PMID: 25901890]
[15]
Nwokolo CU, Mistry P, Pounder RE. The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Alimentary pharmacology & therapeutics. 1990 Apr:4(2):163-9
[PubMed PMID: 2104082]
[16]
Sheele J, Cartowski J, Dart A, Poddar A, Gupta S, Stashko E, Ravi BS, Nelson C, Gupta A. Saccharomyces boulardii and bismuth subsalicylate as low-cost interventions to reduce the duration and severity of cholera. Pathogens and global health. 2015 Sep:109(6):275-82. doi: 10.1179/2047773215Y.0000000028. Epub 2015 Aug 11
[PubMed PMID: 26260354]
[18]
Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. The New England journal of medicine. 1995 Oct 12:333(15):984-91
[PubMed PMID: 7666920]
[19]
McNulty CA. Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori. Reviews of infectious diseases. 1990 Jan-Feb:12 Suppl 1():S94-8
[PubMed PMID: 2406863]
[20]
Koletzko S, Jones NL, Goodman KJ, Gold B, Rowland M, Cadranel S, Chong S, Colletti RB, Casswall T, Elitsur Y, Guarner J, Kalach N, Madrazo A, Megraud F, Oderda G, H pylori Working Groups of ESPGHAN and NASPGHAN. Evidence-based guidelines from ESPGHAN and NASPGHAN for Helicobacter pylori infection in children. Journal of pediatric gastroenterology and nutrition. 2011 Aug:53(2):230-43. doi: 10.1097/MPG.0b013e3182227e90. Epub
[PubMed PMID: 21558964]
Level 1 (high-level) evidence
[21]
Choi J, Jang JY, Kim JS, Park HY, Choe YH, Kim KM. Efficacy of two triple eradication regimens in children with Helicobacter pylori infection. Journal of Korean medical science. 2006 Dec:21(6):1037-40
[PubMed PMID: 17179683]
[22]
Castelli F, Saleri N, Tomasoni LR, Carosi G. Prevention and treatment of traveler's diarrhea. Focus on antimicrobial agents. Digestion. 2006:73 Suppl 1():109-18
[PubMed PMID: 16498259]
[23]
Hill DR, Ericsson CD, Pearson RD, Keystone JS, Freedman DO, Kozarsky PE, DuPont HL, Bia FJ, Fischer PR, Ryan ET, Infectious Diseases Society of America. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Dec 15:43(12):1499-539
[PubMed PMID: 17109284]
[24]
Riddle MS, DuPont HL, Connor BA. ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults. The American journal of gastroenterology. 2016 May:111(5):602-22. doi: 10.1038/ajg.2016.126. Epub 2016 Apr 12
[PubMed PMID: 27068718]
[25]
Vilaichone RK, Prapitpaiboon H, Gamnarai P, Namtanee J, Wongcha-um A, Chaithongrat S, Mahachai V. Seven-Day Bismuth-based Quadruple Therapy as an Initial Treatment for Helicobacter pylori Infection in a High Metronidazole Resistant Area. Asian Pacific journal of cancer prevention : APJCP. 2015:16(14):6089-92
[PubMed PMID: 26320500]
[26]
Borbinha C, Serrazina F, Salavisa M, Viana-Baptista M. Bismuth encephalopathy- a rare complication of long-standing use of bismuth subsalicylate. BMC neurology. 2019 Aug 29:19(1):212. doi: 10.1186/s12883-019-1437-9. Epub 2019 Aug 29
[PubMed PMID: 31464594]
[27]
Sainsbury SJ. Fatal salicylate toxicity from bismuth subsalicylate. The Western journal of medicine. 1991 Dec:155(6):637-9
[PubMed PMID: 1812638]
[28]
Rao G, Aliwalas MG, Slaymaker E, Brown B. Bismuth revisited: an effective way to prevent travelers' diarrhea. Journal of travel medicine. 2004 Jul-Aug:11(4):239-41
[PubMed PMID: 15541227]
[29]
Lambert JR. Pharmacology of bismuth-containing compounds. Reviews of infectious diseases. 1991 Jul-Aug:13 Suppl 8():S691-5
[PubMed PMID: 1925310]
[30]
Hogan DB, Harbidge C, Duncan A. Bismuth Toxicity Presenting as Declining Mobility and Falls. Canadian geriatrics journal : CGJ. 2018 Dec:21(4):307-309. doi: 10.5770/cgj.21.323. Epub 2018 Dec 30
[PubMed PMID: 30595782]